Skip to main content
Zai Lab Limited logo

Zai Lab Limited — Investor Relations & Filings

Ticker · 9688 ISIN · KYG9887T1168 LEI · 549300P2UYQ9U5LY1T58 HKEX Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2023-03-20 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 9688

About Zai Lab Limited

http://www.zailaboratory.com

Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing transformative therapies that address medical conditions with significant unmet needs. The company focuses its pipeline and development efforts across four core therapeutic areas: oncology, immunology, neuroscience, and infectious disease. Zai Lab employs a strategy of internal research and global partnerships to advance best-in-class and first-in-class medicines. A key commercial product is ZEJULA (niraparib), utilized as a maintenance treatment for ovarian cancer in markets including mainland China.

Recent filings

Filing Released Lang Actions
NOTICE OF BOARD ACTION
Report Publication Announcement Classification · 95% confidence The document is a short announcement from the board of directors of Zai Lab Limited regarding the upcoming consideration and approval of the annual results for the year ended December 31, 2022. It references that the annual results have already been announced and filed with the SEC as a Form 10-K on March 1, 2023. The announcement states that the annual results to be published in Hong Kong will be the same as those previously filed, with some additional information for HK Listing Rules compliance. The document is only 2321 characters long and primarily serves to notify the market of the board's planned action and the publication of the annual results, rather than containing the full annual report or detailed financial data itself. According to the "Menu vs Meal" rule, such a short announcement that states the report will be published or has been filed elsewhere should be classified as a Report Publication Announcement (RPA), not as the Annual Report (10-K) itself.
2023-03-20 English
Inside Information Announcement
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the closure of Silicon Valley Bank and its impact on the company's cash holdings and operations. It is labeled as an "INSIDE INFORMATION ANNOUNCEMENT" and references regulatory rules for disclosure (Rule 13.09 of the Listing Rules and Part XIVA of the Securities and Futures Ordinance). The content is a brief update on a specific event affecting the company’s financial position but does not contain financial statements, detailed financial analysis, or comprehensive reporting. The document length is short (2530 characters), and it serves as a regulatory disclosure rather than a full report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-12 English
GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the grant of share options and restricted share units under the company's 2022 Equity Incentive Plan. It details the number of options and restricted share units granted, the vesting periods, exercise prices, and other terms related to the equity incentive plan. The announcement references compliance with Listing Rules and provides definitions related to the share plan. There is no indication that this is a full financial report, audit report, or earnings release. It is not a report of management changes or voting results. The content is focused on equity compensation grants to employees, which fits the category of a share issue or capital change announcement. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is sufficient and contains substantive details about the share option grants, not merely a brief notice or report publication announcement.
2023-03-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Major Shareholding Notification Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to securities issued by Zai Lab Limited. It includes data on authorized and issued shares, share option schemes, and confirmations of compliance with listing rules. The document is submitted to the Hong Kong Exchanges and Clearing Limited and is titled as a 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities.' This type of filing is a regulatory disclosure about share capital and share movements rather than a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data but focuses on share capital changes and confirmations. Therefore, it fits best under the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels and related share capital movements.
2023-03-06 English
GRANT OF RESTRICTED SHARES
Director's Dealing Classification · 95% confidence The document is an announcement regarding the grant of restricted shares to an independent director under the company's equity incentive plan. It details the number of shares granted, the vesting schedule, the price, and the reasons for the grant. The document references compliance with listing rules and provides definitions related to the equity plan. There are no financial statements, earnings data, or comprehensive management discussion. The content focuses on a share-based compensation event for a board member, which is a change related to directors' dealings or compensation. Given the nature of the announcement—granting restricted shares to a director—and the absence of financial report data, this fits best under Director's Dealing (DIRS), which covers personal share transactions by company directors and executives (insider trades). The document is not a full report, nor an earnings release or management report. Therefore, the classification is DIRS with high confidence.
2023-03-06 English
OVERSEAS REGULATORY ANNOUNCEMENT
Annual Report Classification · 100% confidence The document is an announcement by Zai Lab Limited regarding the filing of their annual report on Form 10-K for the fiscal year ended December 31, 2022. The text includes the full Form 10-K filing with the U.S. Securities and Exchange Commission, including detailed sections such as Business, Risk Factors, Legal Proceedings, Management's Discussion and Analysis, Financial Statements, and more. The document is lengthy (15,000 characters) and contains substantive financial data and comprehensive company information typical of an annual report. The presence of the Form 10-K label, the detailed table of contents, and the inclusion of financial and management discussion sections confirm this is the full annual report, not just an announcement or summary. Therefore, the correct classification is Annual Report (10-K).
2023-03-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.